Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole

Bennison, C., Stephens, S., Lescrauwaet, B. et al. (2 more authors) (2016) Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole. Journal of Market Access & Health Policy, 4. ISSN 2001-6689

Abstract

Metadata

Authors/Creators:
  • Bennison, C.
  • Stephens, S.
  • Lescrauwaet, B.
  • Van Hout, B.
  • Jackson, T.L.
Copyright, Publisher and Additional Information: © 2016 Craig Bennison et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license
Keywords: anatomical outcomes; economic evaluation; quality adjusted life year; United Kingdom; vitrectomy; PPV; symptomatic vitreomacular adhesion
Dates:
  • Published: 23 June 2016
  • Accepted: 30 May 2016
  • Published (online): 23 June 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 16 Sep 2016 10:16
Last Modified: 16 Sep 2016 10:16
Published Version: https://dx.doi.org/10.3402/jmahp.v4.31472
Status: Published
Publisher: Co-Action Publishing
Refereed: Yes
Identification Number: https://doi.org/10.3402/jmahp.v4.31472

Share / Export

Statistics